Quick Answer
FibroBiologics, Inc. reported Net Income of -$18.65 million for fiscal year 2025.
FibroBiologics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$18.65M | -67.1% |
| 2024 | -$11.16M | +32.3% |
| 2023 | -$16.48M | -221.9% |
| 2022 | -$5.12M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.78M | -1055.6% | -24.0% |
| June 30, 2025 | -$4.66M | -618.7% | +6.2% |
| March 31, 2025 | -$4.97M | +41.3% | -893.2% |
| September 30, 2024 | -$500.0K | +77.2% | -155.7% |
| June 30, 2024 | $898.0K | +141.6% | +110.6% |
| March 31, 2024 | -$8.46M | -250.3% | -285.8% |
| September 30, 2023 | -$2.19M | — | -1.5% |
| June 30, 2023 | -$2.16M | — | +10.6% |
- FibroBiologics, Inc. showed a decrease of -67.1% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, FibroBiologics, Inc.’s net income has declined by 264.1% (from -$5.12 million to -$18.65 million).
- The most recent figure is from FibroBiologics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: